Liquidia (LQDA) Sales of Property, Plant and Equipment (2022 - 2024)

Liquidia (LQDA) Sales of Property, Plant and Equipment (2022 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Haleon	43.92 Bn	42.96 Bn	-	-
2	Teva Pharmaceutical Industries	43.19 Bn	39.53 Bn	2.15 Bn	-
3	Zoetis	31.74 Bn	30.06 Bn	1.05 Bn	1.00 Mn
4	Takeda Pharmaceutical	28.67 Bn	22.87 Bn	5.10 Bn	6.88 Mn
5	United Therapeutics	22.22 Bn	19.56 Bn	683.80 Mn	-
6	Viatris	18.71 Bn	17.83 Bn	1.46 Bn	8.20 Mn
7	Neurocrine Biosciences	15.55 Bn	15.16 Bn	935.80 Mn	-
8	Elanco Animal Health	11.80 Bn	11.27 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Liquidia	6.37 Bn	6.08 Bn	160.92 Mn	-

Download Data